• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

ASCO Audio Journal of Oncology in Advance – June 15th, 2007 – reporting from: ASCO Annual Meeting, Chicago, June 1-5, 2007

  • in AJO · ASCO · Oncology
  • — 16 Jun, 2007
Christiane Kuhl
Christiane Kuhl
Julie Gralow
Julie Gralow

MRI Better Than Mammography for Detecting High-Grade Ductal Carcinoma In Situ?

REFERENCE: 1504, ASCO Annual Meeting Chicago June 1-5, 2007
CHRISTIANE KUHL, University of Bonn, Germany
COMMENT: JULIE GRALOW, University of Washington, Seattle

The ASCO meeting in Chicago heard findings from Germany that suggested MRI was better than mammography for the detection of ductal carcinoma in situ, or preinvasive breast cancer. Derek Thorne spoke to Christiane Kuhl, from the University of Bonn, about her team’s provocative data, while Julie Gralow of the University of Washington commented on how this study could affect clinical practice.

Priya Rastogi
Priya Rastogi

No Increase in Time of Cardiac Toxicity From Trastuzumab

REFERENCE: LBA 513, ASCO Annual Meeting Chicago June 1-5, 2007
PRIYA RASTOGI, University of Pittsburgh
COMMENT: JULIE GRALOW, University of Washington, Seattle

The latest data from the large NSABP B-31 trial, which looked at trastuzumab in breast cancer, have provided some reassurance that the drug’s cardiac toxicity does not continue to grow over time. Priya Rastogi of the University of Pittsburgh School of Medicine told Derek Thorne about the findings, and she also explained her group’s new model, which could help doctors assess the risk to patients in this situation. Julie Gralow commented on her findings.

To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.

Tags: ajoiaASCOcarcinomacardiacChristiane KuhlJulie GralowmamographyMRIPriya Rastogitoxicitytrastuzumab

You may also like...

  • Endothelin Antagonist Keeps Patients with Hormone Refractory Prostate Cancer Alive Longer Endothelin Antagonist Keeps Patients with Hormone Refractory Prostate Cancer Alive Longer 2 Nov, 2007
  • Long Overall Survival in Ceritinib-Treated ALK-Positive Lung Cancer 27 Oct, 2018
  • Oncology Times Broadcast News with the Audio Journal of Oncology – Cancer Related Fatigue Questionnaires Assessed Oncology Times Broadcast News with the Audio Journal of Oncology – Cancer Related Fatigue Questionnaires Assessed 6 Apr, 2009
  • Live Report from ASH:<br />Ibritumomab Provides Benefit in Patients with Follicular Lymphoma Live Report from ASH:
    Ibritumomab Provides Benefit in Patients with Follicular Lymphoma
    11 Dec, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story ASCO Annual Meeting Daily News Podcasts – June 5th, 2007
  • Next story Simple Intervention Could Significantly Improve TB Detection in Women
  • News

    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
    • MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014
  • Related interviews

    • Women With DCIS Live Longer Than General Population
    • Nuclear War: The Facts Today
    • Lung Cancer Radiation Therapy Increases Heart…
    • Young Women with HER2+ Early Breast Cancer Better…
    • Gene Assay Predicts Which Patients Need Radiation…
  • Home
  • Oncology
  • AJO
  • ASCO Audio Journal of Oncology in Advance – June 15th, 2007 – reporting from: ASCO Annual Meeting, Chicago, June 1-5, 2007

© COPYRIGHT 2013 AUDIOMEDICA.COM.